GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,157,000 | -3.2% | 669,348 | -2.0% | 0.44% | +0.9% |
| Q4 2021 | $30,119,000 | +15.7% | 682,978 | +0.3% | 0.43% | +14.3% |
| Q3 2021 | $26,025,000 | -4.6% | 681,113 | -0.6% | 0.38% | +3.6% |
| Q2 2021 | $27,281,000 | +18.2% | 685,113 | +5.9% | 0.36% | +15.6% |
| Q1 2021 | $23,087,000 | -2.5% | 646,868 | +0.6% | 0.32% | -2.8% |
| Q4 2020 | $23,669,000 | -8.1% | 643,168 | -6.0% | 0.32% | -19.2% |
| Q3 2020 | $25,764,000 | -16.5% | 684,478 | -9.5% | 0.40% | -12.1% |
| Q2 2020 | $30,846,000 | +4.9% | 756,208 | -2.6% | 0.46% | -9.5% |
| Q1 2020 | $29,412,000 | -19.6% | 776,258 | -0.3% | 0.50% | +38.1% |
| Q4 2019 | $36,595,000 | +5.1% | 778,783 | -4.5% | 0.36% | +2.5% |
| Q3 2019 | $34,815,000 | +1.4% | 815,723 | -4.9% | 0.36% | +2.9% |
| Q2 2019 | $34,326,000 | -9.7% | 857,723 | -5.7% | 0.35% | -8.7% |
| Q1 2019 | $38,006,000 | +1.6% | 909,443 | -7.1% | 0.38% | -8.7% |
| Q4 2018 | $37,419,000 | -7.2% | 979,298 | -2.4% | 0.42% | +10.7% |
| Q3 2018 | $40,326,000 | -3.0% | 1,003,883 | -2.7% | 0.38% | -1.3% |
| Q2 2018 | $41,574,000 | +1.8% | 1,031,358 | -1.3% | 0.38% | -1.0% |
| Q1 2018 | $40,846,000 | +12.1% | 1,045,463 | +1.7% | 0.38% | +20.0% |
| Q4 2017 | $36,452,000 | -10.0% | 1,027,688 | +3.0% | 0.32% | -12.8% |
| Q3 2017 | $40,506,000 | -5.4% | 997,688 | +0.5% | 0.37% | -12.4% |
| Q2 2017 | $42,821,000 | +0.8% | 993,063 | -1.4% | 0.42% | +5.3% |
| Q1 2017 | $42,482,000 | +8.2% | 1,007,638 | -1.1% | 0.40% | +10.6% |
| Q4 2016 | $39,249,000 | -14.6% | 1,019,198 | -4.3% | 0.36% | -16.3% |
| Q3 2016 | $45,944,000 | -2.7% | 1,065,243 | -2.2% | 0.43% | -4.4% |
| Q2 2016 | $47,227,000 | +5.5% | 1,089,693 | -1.3% | 0.45% | +1.8% |
| Q1 2016 | $44,777,000 | -3.2% | 1,104,243 | -3.7% | 0.44% | -7.7% |
| Q4 2015 | $46,279,000 | +0.8% | 1,146,943 | -4.0% | 0.48% | +2.4% |
| Q3 2015 | $45,923,000 | -8.9% | 1,194,368 | -1.3% | 0.47% | +1.3% |
| Q2 2015 | $50,390,000 | -1.1% | 1,209,853 | +9.5% | 0.46% | -4.0% |
| Q1 2015 | $50,969,000 | +9.0% | 1,104,413 | +0.9% | 0.48% | +17.6% |
| Q4 2014 | $46,777,000 | +5080.2% | 1,094,463 | +5469.8% | 0.41% | +5012.5% |
| Q3 2014 | $903,000 | -14.1% | 19,650 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $1,051,000 | -3.1% | 19,650 | -3.2% | 0.01% | -11.1% |
| Q1 2014 | $1,085,000 | +0.1% | 20,300 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $1,084,000 | -4.3% | 20,300 | -10.1% | 0.01% | -10.0% |
| Q3 2013 | $1,133,000 | +1.0% | 22,590 | +0.6% | 0.01% | -9.1% |
| Q2 2013 | $1,122,000 | – | 22,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |